Clinical Trials Logo

Clinical Trial Summary

The objective of the present study to analyze the vaginal microbiome in patients who have not achieved gestation after oocyte donation treatment and after probiotic administration. All patients will receive vaginal probiotic according to the standard regimen. Sample collection will be performed the embryo transfer day and on the day of the pregnancy test. Follow up of gestation will be carried out. The analysis of the vaginal microbiome will be performed though massive genetic sequencing (determination of 16SRNA). The study variables, among others, are vaginal microbiome pattern after probiotic administration, the gestation rate, and the abortion rate.


Clinical Trial Description

This study will be performed after the observational study "Vaginal microbiome influence on the results of assisted reproduction techniques". The main goal of this previous study will be to identify patterns of vaginal and / or endometrial microbiome in relation to the gestation rate in women with implantation failure and / or repeat abortions who undergo an oocyte donation treatment. The vaginal and endometrial microbiome of women with (i) implantation failure, (ii) repeat abortions and (iii) control group without implantation failure or repeat abortions, will be analyzed before and after the embryo transfer. Those women who do not achieve pregnancy will be eligible for the present study. The objective of the present study to analyze the vaginal microbiome in patients who have not achieved gestation after oocyte donation treatment and after probiotic administration. All patients will receive vaginal probiotic according to the standard regimen: 1 tablet (via vaginal) for 5 days after menstruation during the same cycle of the next embryo transfer. The vaginal sample will be analyzed after taking the probiotic. Sample collection will be performed the embryo transfer day and on the day of the pregnancy test. Follow up of gestation will be carried out. Vaginal sample collection: obtention of vaginal fluid with vaginal swab by direct visualization. Direct visualization means having the patient in a lithotomy position, like a routine gynecological examination by visualization with a vaginal speculum. The analysis of the vaginal microbiome will be performed though massive genetic sequencing (determination of 16SRNA). First of all, the extraction of RNA and subsequent analysis. We will analyze the groups of microorganisms, as well as the determination of patterns related to failure of implantation, repetitive abortions and gestation success. The study variables, among others, are vaginal microbiome pattern after probiotic administration, the gestation rate, and the abortion rate. The vaginal microbiome will be compared with the results of the previous observational study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03153787
Study type Interventional
Source Instituto Bernabeu
Contact
Status Completed
Phase N/A
Start date June 1, 2017
Completion date May 1, 2019

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT01689454 - ISM1 Versus EmbrioGen Media for Embryo Culture With Previous Failure Implantation in ART Treatments Phase 3
Completed NCT03843112 - Modulating the Vaginal Microbiome After Implantation Failure Phase 4
Recruiting NCT01111799 - Does Local Injury of the Endometrium Improve Controlled Ovarian Hyperstimulation (COH) + Intrauterine Insemination (IUI) Outcome? N/A
Recruiting NCT06097559 - International Non-selection Study for ERA® Test in Patients With Previous Implantation Failures
Recruiting NCT01800513 - Endometrial Biopsy Prior to IVF in Those Patients With Prior Implantation Failure N/A
Completed NCT01673399 - Oxytocin Antagonist in Patients With Repeated Failure of Implantation Phase 4
Active, not recruiting NCT03558399 - Frozen Blastocyst Transfer Using Conventional Timing Versus Timing by Endometrial Receptivity Analysis N/A